Executive Vice President of $GD sells 19,793 shares in insider sale

their portfolio in Q1 2025, for an estimated $1,250,472,743. PRICE T ROWE ASSOCIATES INC/MD/ removed 3,205,377 shares (-89.4%) from their portfolio in Q1 2025, for an estimated $873,721,662. BANK OF AMERICA CORP/DE/ added 1,307,677 shares (+17.7%) to their portfolio in Q1 2025, for an estimated $356,446,596. GAMMA INVESTING LLC removed 1,238,844 shares (-99.5%) from their portfolio in Q2 2025, for an estimated $361,321,241. MORGAN STANLEY added 1,226,836 shares (+22.9%) to their portfolio in Q1 2025, for an estimated $334,410,956. CASTLEKEEP INVESTMENT ADVISORS LLC removed 1,056,227 shares (-99.5%) from their portfolio in Q1 2025, for an estimated $287,906,355. AMERIPRISE FINANCIAL INC added 709,782 shares (+34.8%) to their portfolio in Q1 2025, for an estimated $193,472,377. To keep track of hedge funds’ stock portfolios, you can use Quiver Quantitative’s institutional holdings dashboard. $GD Congressional Stock Trading Members of Congress have traded $GD stock 4 times in the past 6 months. Of those trades, 1 was a purchase and 3 were sales. Here is the recent trading activity of $GD stock by members of Congress over the last 6 months: SENATOR JOHN BOOZMAN sold up to $15,000 on 05/20. REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 05/15. REPRESENTATIVE JULIE JOHNSON purchased up to $15,000 on 05/02. REPRESENTATIVE TIM MOORE sold up to $15,000 on 02/20. To track congressional stock trading, visit Quiver Quantitative’s congressional trading dashboard. $GD Analyst Ratings Wall Street analysts have provided reports on $GD in the recent months. There have been 7 firms issuing buy ratings on the stock, and none have issued sell ratings. Some of the recent analyst ratings include: Barclays issuing an “Overweight” rating on 07/29/2025, Wolfe Research issuing an “Outperform” rating on 07/24/2025, Citigroup issuing a “Buy” rating on 07/24/2025, Susquehanna issuing a “Positive” rating on 07/24/2025, JP Morgan issuing an “Overweight” rating on 07/24/2025, TD Cowen issuing a “Buy” rating on 06/25/2025, and TD Securities issuing a “Buy” rating on 04/24/2025. For the latest analyst ratings and price targets for $GD, check out Quiver Quantitative’s $GD forecast page. $GD Price Targets Numerous analysts have given price targets for $GD recently. There have been 12 analysts offering price targets for $GD in the last 6 months, with a median target of $343.5. Some of the recent targets include David Strauss from Barclays setting a target price of $350.0 on 07/29/2025, Myles Walton from Wolfe Research setting a target price of $360.0 on 07/24/2025, Charles Minervino from Susquehanna setting a target price of $365.0 on 07/24/2025, Jason Gursky from Citigroup setting a target price of $368.0 on 07/24/2025, Gavin Parsons from UBS setting a target price of $333.0 on 07/24/2025, Seth Seifman from JP Morgan setting a target price of $345.0 on 07/24/2025, and Peter Arment from Baird setting a target price of $350.0 on 07/24/2025. Please note that this article is not providing financial advice. See Quiver Quantitative’s disclaimers for more details.